{"id":11887,"date":"2026-03-09T17:57:57","date_gmt":"2026-03-09T17:57:57","guid":{"rendered":"https:\/\/medical-article.com\/?p=11887"},"modified":"2026-03-09T17:57:57","modified_gmt":"2026-03-09T17:57:57","slug":"alfasigma-pays-300m-for-rights-to-gsk-rare-liver-disease-drug-on-track-for-fda-decision","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=11887","title":{"rendered":"Alfasigma Pays $300M for Rights to GSK Rare Liver Disease Drug On Track for FDA Decision"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2026\/03\/alfasigma-gsk-primary-biliary-cholangitis-pbc-rare-liver-disease-pruritus-linerixibat-ibat-inhibitor\/\"><\/a><\/p>\n<p>GSK licensed to Alfasigma global rights to linerixibat, a drug developed to treat the rare liver disease primary biliary cholangitis (PBC). The move follows Alfasigma\u2019s 2025 voluntary market withdrawal of Ocaliva, a PBC drug that had sparked safety concerns from U.S. and European regulators. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/03\/alfasigma-gsk-primary-biliary-cholangitis-pbc-rare-liver-disease-pruritus-linerixibat-ibat-inhibitor\/\">Alfasigma Pays $300M for Rights to GSK Rare Liver Disease Drug On Track for FDA Decision<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>GSK licensed to Alfasigma global rights to linerixibat, a drug developed to treat the rare liver disease primary biliary cholangitis (PBC). The move follows Alfasigma\u2019s 2025 voluntary market withdrawal of Ocaliva, a PBC drug that had sparked safety concerns from U.S. and European regulators. The post Alfasigma Pays $300M for Rights to GSK Rare Liver&#8230;<\/p>\n","protected":false},"author":0,"featured_media":11888,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-11887","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/11887"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11887"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/11887\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/11888"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}